Health
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease – nejm.org
Original Article from The New England Journal of Medicine — Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
From Brigham and Womens Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B., C.P.C., B.M.S.); Colorado Prevention Center Clinical Research and Department of Medicine, Division of Cardiovascular Medicine, University of Colorado Anschutz Medical Campus, Aurora (M.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.); the University of Michigan, Ann Arbor (B.P.); Li Ka Shing Knowledge Institute and the Division of Endocrinology and Metabolism,…
-
Business24 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News18 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business19 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Business17 hours agoEverything you need to know about the Coles dividend